ABOUT

HISTORY

  • 2022
  • 07
    Series B - KDB Bank / DONG-A SOCIO HOLDINGS / KOLON Investment / KIWOOM Securities Co., Ltd. / CEO of the DB, Nam Ho Kim
    06
    LNP mass production technology patent application (Microfluidic technology)
    06
    MG-G101 patent application
    03
    MEPS-TBC cryopreservation patent grant
  • 2021
  • 11
    MG-PE3 PCT application
    09
    MEPS-TBC, Manufactured & Released
    08
    Series A (Bridge) – Korea Investment Partners Co., Ltd / SBI Investment Korea Co., Ltd. / KNOTUS Co., Ltd. / Tiumbio Co., Ltd
    04
    MG-PE3 patent granted in Republic of Korea
    03
    Started CRO evaluation of MG-PE3, new drug candidate for Alzheimer's disease - 1st Drug efficacy
    02
    Kicked off MEPS-BBB research service using new drug candidates with pharmaceutical companies
    01
    Expansion & relocation of the office, R&D center, and production facility (Hanyang Tower, 12, Beobwon-ro-11-gil, Songpa-gu, Seoul, Rep. of Korea)
  • 2020
  • 12
    Finished PK/PD CRO evaluation of MG-PE3, new drug candidate for Alzheimer's disease
    10
    Venture Business Certification
    08
    MEPS-TBC patent application (KR/US/PCT) & design application (KR/US/EU) MG-PE3 patent application (KR)
    08
    Series A – Korea Investment Partners Co., Ltd / Tiumbio Co., Ltd
    05
    Finalized technology transfer agreement with Georgia Tech. Registered Mepsgenlab as a subsidiary of Mepsgen
  • 2019
  • 12
    Angel investment
    09
    Founded Mepsgenlab Inc. (USA)
    08
    Founded Mepsgen Co., Ltd. (Rep. of Korea)

Sitemap닫기

ABOUT
OVERVIEW
VISION
HISTORY
LEADERSHIP
ORGANIZATION
OVERSEAS
CI
CONTACT
TECHNOLOGY
HUMAN ORGAN-ON-A-CHIP
BIOMIMETIC NANOPARTICLE
NANOPARTICLE MANUFACTURING
PIPELINE
MEPS-X
MG-X
SERVICE
SERVICE
NEWS
NOTICE
MEDIA
ARTICLE
CAREERS
CULTURE
HIRING PROCESS
WE'RE HIRING!